SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022613
Filing Date
2019-11-13
Accepted
2019-11-13 09:01:56
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atos20190930_10q.htm 10-Q 642951
2 EXHIBIT 31.1 ex_160114.htm EX-31.1 11559
3 EXHIBIT 31.2 ex_160115.htm EX-31.2 12125
4 EXHIBIT 32.1 ex_160116.htm EX-32.1 6115
5 EXHIBIT 32.2 ex_160117.htm EX-32.2 6669
  Complete submission text file 0001437749-19-022613.txt   3500668

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atos-20190930.xml EX-101.INS 667662
7 XBRL TAXONOMY EXTENSION SCHEMA atos-20190930.xsd EX-101.SCH 39883
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atos-20190930_cal.xml EX-101.CAL 31590
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atos-20190930_def.xml EX-101.DEF 259386
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atos-20190930_lab.xml EX-101.LAB 238483
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atos-20190930_pre.xml EX-101.PRE 284144
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 191211844
SIC: 2834 Pharmaceutical Preparations